The New England Journal of Medicine Publishes Phase I Data on Glivec, An Investigational Anti-Cancer Therapy
(PR Newswire)...Also featured in this issue of the NEJM is a case history of the treatment of a patient with a gastrointestinal stromal tumor (GIST).......GISTs are solid tumors that express an activated protein shown to be inhibited by Glivec.......including hormone refractory prostate cancer, gliomas (a cancer of the brain) and small-cell lung cancer....- Apr 04 5:00 PM ET
IF the story does not appear below, Click HERE to view the text of the story!
Note: The original website is displayed below - we have no control over it and are not responsible for the content of it, we just report it! IF you click on anything below, it will take you off of our website!
Original Source: http://biz.yahoo.com/prnews/010404/nyw102.html
(Everything below this line is from VirtualTrials.com!)
Click HERE to return to brain tumor news headlines